KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Notes Payables (2018 - 2024)

Historic Notes Payables for Cme (CME) over the last 9 years, with Q4 2024 value amounting to $749.8 million.

  • Cme's Notes Payables changed N/A to $749.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $749.8 million, marking a year-over-year change of. This contributed to the annual value of $749.8 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q4 2024, Cme's Notes Payables is $749.8 million.
  • Cme's 5-year Notes Payables high stood at $749.8 million for Q4 2024, and its period low was $14.5 million during Q3 2022.
  • For the 4-year period, Cme's Notes Payables averaged around $504.9 million, with its median value being $749.3 million (2024).
  • Per our database at Business Quant, Cme's Notes Payables tumbled by 9806.46% in 2022 and then surged by 449693.25% in 2024.
  • Quarter analysis of 4 years shows Cme's Notes Payables stood at $749.4 million in 2021, then crashed by 97.86% to $16.0 million in 2022, then grew by 1.88% to $16.3 million in 2023, then skyrocketed by 4500.0% to $749.8 million in 2024.
  • Its last three reported values are $749.8 million in Q4 2024, $749.7 million for Q3 2024, and $749.5 million during Q2 2024.